World Health Organization members today raised strong concerns that a working group they mandated last May to address problems with WHO policy on counterfeit and substandard medicines has yet to be formed – with four months remaining before it must report back to members.
One delegation called for a halt to WHO activities on anti-counterfeiting until the outcome of the working group is accepted by member states.
WHO Director General Margaret Chan told members of the WHO Executive Board today that a first meeting of a dedicated working group would be held in late February. The Board is meeting from 17-25 January.
For full article, please see IPWatch.
Learn about OpSec's Anti-Counterfeiting Solutions.